Showing results (31-40 of 151) with videos related to
Sort By:
Pageof 16
Blood|May 1, 1991
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemiaE Archimbaud, V Leblond, M Michallet, et al.Therapeutic Drug Monitoring|January 1, 1990
Bayesian estimation of cyclosporine clearance in bone marrow graftF Serre-Debeauvais, A Iliadis, B Tranchand, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trialE Archimbaud, X Thomas, V Leblond, et al.Blood|August 15, 1995
Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT GroupM Attal, D Blaise, G Marit, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic LeukemiaC Sebban, E Lepage, J P Vernant, et al.Leukemia|June 1, 1995
Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (< 100 days). The SFGM (Société Française de Greffe de MoelleE Jourdan, D Maraninchi, J Reiffers, et al.Leukemia & Lymphoma|December 29, 1999
Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II studyA Belhabri, X Thomas, J Troncy, et al.Stem Cells (Dayton, Ohio)|August 1, 1995
An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow TransplantationG Gahrton, S Tura, P Ljungman, et al.Leukemia|November 17, 2006
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensusP Dreger, P Corradini, E Kimby, et al.Lancet (London, England)|July 25, 1987
Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemiasD Maraninchi, E Gluckman, D Blaise, et al.Pageof 16